| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
October 25, 2022 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2022 -12-14
Complex macromolecules are becoming a mainstay of pharmaceutical strategy, and the ability to successfully develop these biologics into viable commercial drugs is accelerating at a significant rate. Often, aggressive timelines are imposed on development projects with the aim of getting to First-in-Human trials as soon as possible. However, formulation development can be met with many challenges as biologics are often sensitive molecules with a variety of competing degradation possibilities.
Various approaches have been employed to expedite formulation decisions, yet there are many pros and cons to these approaches. Ultimately, the unified goal is to create a well-characterized pharmaceutical product with demonstrated safety and efficacy, and formulation development plays a critical role in this pursuit. Sharing of knowledge and best practices allows the entire community to build a foundation to achieve these goals and to advance science from curiosity to cure.
Join the featured speaker to explore biologics formulations development tools, tricks and methods and learn ways to utilize these in pragmatic and efficient ways.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Tyler H. Jones, Director, Formulation, Curia Global, Inc.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2022 -12-14
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|